Abstract

Plasmodium falciparum is a major cause of severe malaria in Southeast Asia, however, there is limited information regarding clinical factors associated with the severity of falciparum malaria from this region. We performed a retrospective case-control study to compare clinical factors and outcomes between patients with severe and non-severe malaria, and to identify clinical factors associated with the requirement for intensive care unit (ICU) admission of patients with severe falciparum malaria among hospitalized adults in Southeast Asia. A total of 255 patients with falciparum malaria in the Hospital for Tropical Diseases in Bangkok, Thailand between 2006 and 2012 were included. We identified 104 patients with severe malaria (cases) and 151 patients with non-severe malaria (controls). Patients with falciparum malaria with following clinical and laboratory characteristics on admission (1) referrals, (2) no prior history of malaria, (3) body temperature of >38.5°C, (4) white blood cell counts >10×109/µL, (5) presence of schizonts in peripheral blood smears, and (6) albumin concentrations of <3.5 g/dL, were more likely to develop severe malaria (P<0.05). Among patients with severe malaria, patients who met ≥3 of the 2010 WHO criteria had sensitivity of 79.2% and specificity of 81.8% for requiring ICU admission. Multivariate analysis identified the following as independent associated factors for severe malaria requiring ICU admission; (1) ethnicity of Thai [odds ratio (OR) = 3.601, 95% confidence interval (CI) = 1.011–12.822] or Myanmar [OR = 3.610, 95% CI = 1.138–11.445]; (2) referrals [OR = 3.571, 95% CI = 1.306–9.762]; (3) no prior history of malaria [OR = 5.887, 95% CI = 1.354–25.594]; and (4) albumin concentrations of <3.5 g/dL [OR = 7.200, 95% CI = 1.802–28.759]. Our findings are important for the clinical management of patients with malaria because it can help early identification of patients that could develop severe malaria and require ICU admission. Early identification and the timely initiation of appropriate treatments may well improve the outcomes and reduce the mortality of these patients.

Highlights

  • Malaria is caused by various species of the protozoan parasite Plasmodium, namely P. falciparum, P. vivax, P. malariae, P. ovale and P. knowlesi

  • Of the 255 patients diagnosed with falciparum malaria, 104 met the 2010 World Health Organization (WHO) criteria for severe malaria defined as cases and the remainder of the patients (n = 151) were included in the control group

  • Characteristics of Patients with Severe Falciparum Malaria Of the 255 patients diagnosed with falciparum malaria, 104 met the 2010 WHO criteria for severe malaria

Read more

Summary

Introduction

Malaria is caused by various species of the protozoan parasite Plasmodium, namely P. falciparum, P. vivax, P. malariae, P. ovale and P. knowlesi. P. falciparum and P. vivax are responsible for the majority of infections [1]. Malaria is endemic in 106 countries, and the global death rate due to malaria infection is estimated at 1 million individuals per annum [1]. 40% of the global population at risk of contracting malaria resides in Southeast Asia. In Thailand, 32 million people are at risk of contracting malaria, and the Thai-Cambodia border is known to be an area with a high transmission rate, especially for multi-drug resistant P. falciparum malaria [2]. P. falciparum is a major cause of severe malaria and approximately 10–20% of patients with falciparum malaria require urgent and intensive medical care [3,4,5]

Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call